ARGX

argenx (ARGX)

About argenx (ARGX)

argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.

Details

Daily high

$725.28

Daily low

$705.88

Price at open

52 Week High

$934.62

52 Week Low

$510.06

Market cap

44.4B

Dividend yield

0.00%

Volume

246

Avg. volume

364,576

P/E ratio

34.03

argenx News